Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35
United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Robert Graham Susman
1 May 2026
Director
Sold on a plan
2,502
$27.17
$67.98K
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
1,909
$23.96
$45.74K
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
13,091
$23.14
$302.93K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
2,898
$23.95
$69.41K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
19,351
$23.14
$447.78K
Andrew J. Fromkin
7 Mar 2025
Director
Sold on a plan
1,384
$19.96
$27.62K
Andrew J. Fromkin
7 Mar 2025
Director
Sold on a plan
6,616
$19.52
$129.14K
Douglas J. Hughes
2 Dec 2024
Director
Sold on a plan
5,425
$28.54
$154.83K
Atul Pande
2 Dec 2024
Director
Sold on a plan
7,750
$28.54
$221.19K
George Migausky V
1 Dec 2023
Director
Sold on a plan
5,022
$40.46
$203.19K
George Migausky V
1 Dec 2023
Director
Sold on a plan
3,478
$39.81
$138.46K
George Migausky V
1 Dec 2023
Director
Sold on a plan
4,200
$38.79
$162.92K
Atul Pande
1 Dec 2023
Director
Sold on a plan
4,847
$40.46
$196.11K
Atul Pande
1 Dec 2023
Director
Sold on a plan
3,374
$39.82
$134.35K
Atul Pande
1 Dec 2023
Director
Sold on a plan
4,129
$38.80
$160.21K
Andrew J. Fromkin
1 Dec 2023
Director
Sold on a plan
4,773
$40.46
$193.12K
Andrew J. Fromkin
1 Dec 2023
Director
Sold on a plan
3,636
$39.81
$144.75K
Andrew J. Fromkin
1 Dec 2023
Director
Sold on a plan
3,941
$38.78
$152.83K
Showing 250 of 298 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 324
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 10
Sales at will 231
Transactions with no price 0
Shares from compensation/vesting 84,422,925
Sales filed before the plan box existed 33
History held since 15 May 2019